# Sativa Group appoint King’s College London Professor to the Board

- Link: https://www.directorstalkinterviews.com/sativa-group-appoint-kings-college-london-professor-to-the-board/412797700
- Published: 2019-11-11T08:46:19+00:00
- Author: Amilia Stone

**Sativa Group** ([NEX:SATI](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn)),
the UK’s leading quoted CBD wellness and medicinal cannabis Group, has appointed
Clive Page, Professor of Pharmacology at King’s College London, to its Medical Advisory
Board.  Professor Page’s main research interests are in the pharmacology of inflammation
and respiratory disease, and he has published over 300 scientific papers and book
chapters.  

He was awarded the Sandoz Prize from the British Pharmacological Society in 1988,
The Tanabe Young Investigators Prize from the American College of Clinical Pharmacology
in 1996 and the Society of Biology President’s Medal in 2012 for “Outstanding Contributions
to the Life Sciences”.  He is a Fellow of the Royal Society of Biology and an Honorary
Fellow of the British Pharmacological Society.  Professor Page was awarded an OBE
for “Services to Pharmacology” in 2017.

> **Dr Nick Horniman, Director of Regulatory Affairs at Sativa, said:  **“Professor
> Page is an eminent research scientist and will add to Sativa’s experience, interest
> and understanding in cannabis based medical products.” 

Share on:
